NeurAxis: Should You Buy This IPO? By: TalkMarkets February 08, 2023 at 12:14 PM EST As NeurAxis is ready to launch its IPO, we take a closer look to see if investors should be buying into the hype. Read More >> Related Stocks: AbbVie Amgen Arena Pharmaceuticals Bristol-Myers Squibb Gilead Sciences Masimo Corp Pfizer Takeda Pharmaceutical Ltd ADR
